EVerZom
Created in 2019
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
4,653Activities
Technologies
Entity types
Location
45 Rue des Saints-Pères, 75006 Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 15
SIREN
854006681Engaged corporates
13
13 0Added in Motherbase
1 year, 8 months ago
biotech Value proposition
Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration
EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver.
Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this new field.
The company has successfully developed a multi-patented platform which enables exosome sourcing, generation, loading, and formulation to create proprietary programs and establish early-stage partnerships in the field of regenerative therapy and oncology.
extracellular vesicles, exosomes, bioproduction, drug delivery, regenerative medecine, biodrugs, and cell cultureOriginal language
Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration
EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver.
Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this new field.
The company has successfully developed a multi-patented platform which enables exosome sourcing, generation, loading, and formulation to create proprietary programs and establish early-stage partnerships in the field of regenerative therapy and oncology.
EVerZom - Exosome biotech company
EVerZom is an exosome biotech company developing exosome therapeutics in digestive tissue healing, fistula and organ regeneration.
https://everzom.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 ASSOCIATION FRANCAISE DES POLES DE COMPETITIVITE French Cluster | ASSOCIATION FRANCAISE DES POLES DE COMPETITIVITE French Cluster | Other 7 Nov 2024 | | |
 | Réseau SATT | Other 20 May 2024 | | |
 La French Tech Alpes Government Administration, French Tech | La French Tech Alpes Government Administration, French Tech | Other 31 Mar 2023 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 31 Mar 2023 | | |
 WILCO Software Development | WILCO Software Development | Other 3 Apr 2023 | | |
 La French Tech Grand Paris French Tech, IT Services and IT Consulting | La French Tech Grand Paris French Tech, IT Services and IT Consulting | Other 27 Mar 2023 | | |
 La French Tech Lille French Tech, IT Services and IT Consulting | La French Tech Lille French Tech, IT Services and IT Consulting | Other 27 Mar 2023 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 27 Mar 2023 | | |
 numeum IT Services and IT Consulting | numeum IT Services and IT Consulting | Other 27 Mar 2023 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 24 Mar 2023 | | |